Incorrect diagnosis of Clostridium difficile infection in a university hospital in Japan

Journal of Infection and Chemotherapy

Volumn 21, Issue 10, 2015, Pages 718-722

  Mori, Nobuaki ^a   Yoshizawa, Sadako ^b   Saga, Tomoo ^a   Ishii, Yoshikazu ^a,b   Murakami, Hinako ^b   Iwata, Morihiro ^b   Collins, Deirdre A ^c   Riley, Thomas V ^c,d   Tateda, Kazuhiro ^a,b  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

Binary toxin; Clostridium difficile infection; Epidemiology; Incorrect diagnosis; PCR ribotype

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLOSTRIDIUM DIFFICILE INFECTION; DIAGNOSTIC ERROR; DISEASE COURSE; FECES CULTURE; FEMALE; HUMAN; INCIDENCE; JAPAN; MAJOR CLINICAL STUDY; MALE; PEPTOCLOSTRIDIUM DIFFICILE; VERY ELDERLY; CLOSTRIDIUM INFECTIONS; FECES; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; RETROSPECTIVE STUDY; UNIVERSITY HOSPITAL;

ACTIN-SPECIFIC ADP-RIBOSYLTRANSFERASE, CLOSTRIDIUM; BACTERIAL PROTEIN; BACTERIAL TOXIN; ENTEROTOXIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TCDA PROTEIN, CLOSTRIDIUM DIFFICILE; TOXB PROTEIN, CLOSTRIDIUM DIFFICILE;

ADP RIBOSE TRANSFERASES; AGED; BACTERIAL PROTEINS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIAGNOSTIC ERRORS; ENTEROTOXINS; FECES; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; JAPAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84941734543     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2015.06.009     Document Type: Article

References (26)

1. McDonald L.C., Killgore G.E., Thompson A., Owens R.C., Kazakova S.V., Sambol S.P., et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005, 353:2433-2441.
2. Lessa F.C., Gould C.V., McDonald L.C. Current status of Clostridium difficile infection epidemiology. Clin Infecti Dis 2012, 55:S65-S70.
3. Bauer M., Notermans D., Van Benthem B. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011, 377:63-73.
4. Kuijper E.J., Coignard B., Tull P. ESCMID study group for Clostridium difficile, EU member states, European Centre for disease prevention and control. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006, 12(Suppl 6):2-18.
5. McDonald L.C., Coignard B., Dubberke E., Song X., Horan T., Kutty P.K., et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007, 28:140-145.
6. Iwashima Y., Nakamura A., Kato H., Kato H., Wakimoto Y., Wakiyama N., et al. A retrospective study of the epidemiology of Clostridium difficile infection at a university hospital in Japan: genotypic features of the isolates and clinical characteristics of the patients. J Infect Chemother 2010, 16:329-333.
7. Takahashi M., Mori N., Bito S. Multi-institution case-control and cohort study of risk factors for the development and mortality of Clostridium difficile infections in Japan. BMJ Open 2014, 4:e005665.
8. Honda H., Yamazaki A., Sato Y., Dubberke E.R. Incidence and mortality associated with Clostridium difficile infection at a Japanese tertiary care center. Anaerobe 2014, 25:5-10.
9. Kuwata Y., Tanimoto S., Sawabe E., Shima M., Takahashi Y., Ushizawa H., et al. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from a university teaching hospital in Japan. Eur J Clin Microbiol Infect Dis 2015, 34:763-772.
10. Lemee L., Dhalluin A., Testelin S., Mattrat M.A., Maillard K., Lemeland J.F., et al. Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (Toxin A), and tcdB (Toxin B) genes for toxigenic culture of Clostridium difficile. J Clin Microbiol 2004, 42:5710-5714.
11. Stubbs S.L., Brazier J.S., O'Neill G.L., Duerden B.I. PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 1999, 37:461-463.
12. Spigaglia P., Mastrantonio P. Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol 2002, 40:3470-3475.
13. Wong S.S., Woo P.C., Luk W.K., Yuen K.Y. Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and Etest. Diagn Microbiol Infect Dis 1999, 34:1-6.
14. Muto C.A., Pokrywka M., Shutt K., Mendelsohn A.B., Nouri K., Posey K., et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 2005, 26:273-280.
15. Zar F.A., Bakkanagari S.R., Moorthi K.M., Davis M.B. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007, 45:302-307.
16. Davies K.A., Longshaw C.M., Davis G.L., Bouza E., Barbut F., Barna Z., et al. Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect Dis 2014, 14:1208-1219.
17. Alcalá L., Martin A., Marín M., Sánchez-Somolinos M., Catalán P., Peláez T., et al. The undiagnosed cases of Clostridium difficile infection in a whole nation: where is the problem?. Clin Microbiol Infect 2012, 18:E204-E213.
18. Alcalá L., Reigadas E., Marín M., Martin A., Catalán P., Bouza E., et al. Impact of clinical awareness and diagnostic tests on the underdiagnosis of Clostridium difficile infection. Eur J Clin Microbiol Infect Dis 2015, Apr 24., [Epub ahead of print].
19. Peterson L.R., Manson R.U., Paule S.M., Hacek D.M., Robicsek A., Thomson R.B., et al. Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. Clin Infect Dise 2007, 45:1152-1160.
20. Dubberke E.R., Han Z., Bobo L., Hink T., Lawrence B., Copper S., et al. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J Clin Microbiol 2011, 49:2887-2893.
21. Louie T., Miller M., Mullane K. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 2011, 364:422-431.
22. See I., Mu Y., Cohen J., Beldavs Z.G., Winston L.G., Dumyati G., et al. NAP1 strain type predicts outcomes from Clostridium difficile infection. Clin Infect Dis 2014, 58:1394-1400.
23. Kato H., Ito Y., van den Berg R.J., Kuijper E.J., Arakawa Y. First isolation of Clostridium difficile 027 in Japan. Euro Surveill 2006, 12:E070111-E070113.
24. Sawabe E., Kato H., Osawa K., Chida T., Tojo N., Arakawa Y., et al. Molecular analysis of Clostridium difficile at a university teaching hospital in Japan: a shift in the predominant type over a five-year period. Eur J Clin Microbiol Infect Dis 2007, 26:695-703.
25. Nakamura I., Yamaguchi T., Tsukimori A., Sato A., Fukushima S., Mizuno Y., et al. Fiulminant colitis from Clostridium difficile infection, the epidemic strain ribotype 027, in Japan. J Infect Dis 2014, 20:380-383.
26. Collins D.A., Hawkey P.M., Riley T.V. Epidemiology of Clostridium difficile infection in Asia. Antimicrob Resist Infect Control 2013, 2:21.